Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 29, 2023

Diabetes Remission and Relapse Following an Intensive Metabolic Intervention Combining Insulin Glargine/Lixisenatide, Metformin, and Lifestyle Approaches

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
Diabetes Obes Metab 2023 Aug 14;[EPub Ahead of Print], N McInnes, S Hall, HA Lochnan, SB Harris, Z Punthakee, RJ Sigal, I Hramiak, M Azharuddin, JF Liutkus, JF Yale, F Sultan, A Smith, RE Otto, D Sherifali, YY Liu, HC Gerstein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading